Laccourreye Ollivier, Ishoo Edwin, de Mones Erwan, Garcia Dominique, Kania Romain, Hans Stéphane
Department of Otorhinolaryngology-Head and Neck Surgery, Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, University of Paris V, Paris, France.
Ann Otol Rhinol Laryngol. 2005 Jan;114(1 Pt 1):25-34. doi: 10.1177/000348940511400106.
On the basis of a retrospective review of an inception cohort of 135 patients, with an isolated, previously untreated, moderately differentiated to well-differentiated invasive squamous cell carcinoma of the pyriform sinus and a minimum of 3 years of follow-up, consecutively managed with a supracricoid hemilaryngopharyngectomy (SCHLP) at a single tertiary referral care center and locally controlled, the authors review in detail the surgical technique, highlight the potential technical pitfalls, and document the complications and long-term functional outcome. The overall postoperative mortality rate was 3.7%. The overall mortality rate directly related to the SCHLP was 1.5%. A significant surgical complication directly related to SCHLP completion was noted in 9.6% of cases. The mean lengths of time to removal of the tracheotomy and feeding tubes were 9 and 19 days, respectively. The mean duration of hospitalization was 25 days. Normal swallowing without aspiration by the first postoperative month was noted in 64.6% of patients. Temporary grade 1-2 aspiration and grade 3 aspiration were noted in 26.9% and 8.5% of patients, respectively. Overall, in our series, successful oral alimentation without gastrostomy or completion total laryngectomy was achieved in 91.9% of patients by the first postoperative year, and the incidences of permanent gastrostomy, completion total laryngectomy, and aspiration-related death were 0.7%, 1.5%, and 0.7%, respectively. A significant late complication related to the use of postoperative radiotherapy was noted in 26.5% of cases. From a functional point of view, such results suggest that SCHLP should be integrated among the various conservation treatment options available to patients with selected invasive squamous cell carcinoma of the pyriform sinus.
基于对一个起始队列中135例患者的回顾性研究,这些患者患有孤立的、先前未治疗的、中分化至高分化的梨状窝浸润性鳞状细胞癌,且至少随访3年,在单一的三级转诊护理中心连续接受环状软骨上半喉咽切除术(SCHLP)治疗并实现局部控制,作者详细回顾了手术技术,强调了潜在的技术陷阱,并记录了并发症和长期功能结果。总体术后死亡率为3.7%。与SCHLP直接相关的总体死亡率为1.5%。9.6%的病例出现了与SCHLP完成直接相关的重大手术并发症。气管切开术和饲管拔除的平均时间分别为9天和19天。平均住院时间为25天。64. — 6%的患者在术后第一个月吞咽正常且无呛咳。分别有26.9%和8.5%的患者出现暂时性1 - 2级呛咳和3级呛咳。总体而言,在我们的系列研究中,91.9%的患者在术后第一年内成功实现了无需胃造口术或全喉切除术的经口进食,永久性胃造口术、全喉切除术和呛咳相关死亡的发生率分别为0.7%、1.5%和0.7%。26.5%的病例出现了与术后放疗使用相关的重大晚期并发症。从功能角度来看,这些结果表明,对于选定的梨状窝浸润性鳞状细胞癌患者,SCHLP应纳入各种保留治疗方案之中。